Methods of optimizing antibody variable region binding affinity
UA90682C2
Variant fc regions
CA2779559A1
Variant fc regions
EP2154157A2
FC region variants
WO2006046935A1
Methods of optimizing antibody variable region binding affinity
US2005069554A1
Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
WO2004103404A1
Cd20 binding molecules
US2004161802A1
Methods for producing and improving therapeutic potency of binding polypeptides
EP1606314A2
Fc REGION VARIANTS
WO2004071408A2
Aβ BINDING MOLECULES
MXPA05007853A
Human il-1 beta antagonists.
WO2004063335A2
TNF-α BINDING MOLECULES
US2006269549A1
TNF-α binding molecules
BR0316865A
Butyrylcholinesterase variant, nucleic acid, and methods for converting a camptothecin derivative to a topoisomerase inhibitor, and for treating cancer
US7101978B2
TNF-α binding molecules
US7049121B2
Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
EP1446416A1
Tumor specific monoclonal antibodies
CA2430080A1
Eukaryotic expression libraries based on double lox recombination and methods of use
